In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 100361-18-0, name is 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid, introducing its new discovery. Recommanded Product: 100361-18-0
JANSSEN PHARMACEUTICA N.V.; MACIELAG, Mark, J.; WEIDNER-WELLS, Michele, A.; LIN, Shu-Chen
The present invention relates to C-7 isoxazolyl quinoline/naphthyridine derivatives useful as antimicrobial compounds, pharmaceutical compositions comprising said derivatives and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 100361-18-0, and how the biochemistry of the body works.Recommanded Product: 100361-18-0
Reference£º
1,691-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N685 – PubChem